Remove Cardiology Remove Development Remove Hormones Remove Medicine
article thumbnail

New hormone therapies for hot flashes offer enhanced benefits and minimized risk

Scienmag

Yale physician to discuss the most promising developments in estrogen therapy, including new fetal estrogens, during the 2020 NAMS Virtual Annual Meeting Pre-Meeting Symposium CLEVELAND, Ohio (September 28, 2020)–Hormone therapy remains the best proven method for managing menopause symptoms such as hot flashes.

article thumbnail

Bayer delivers on medical innovation fueling transformation of pharma business

The Pharma Data

At its annual Pharma Media Day 2022, Bayer presented the latest developments in the ongoing transformation of its pharmaceuticals business, which is aimed at delivering long-term, sustainable business growth by bringing forward new options for patients. “We

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

A USD 4.2 Billion Myovant/ Pfizer Deal; Audentes Therapeutics’ ASPIRO Trial Free to Proceed; First Generic of Drug for Severe Hypoglycemia Gets Approval; Teleflex Acquires Z-Medica

Delveinsight

Myovant Sciences have decided to put their forces and efforts together to advance the Prostate cancer market as they announced their partnership deal to develop and market relugolix for prostate cancer and women’s health. . Relugolix is a once-daily, oral gonadotropin-release hormone (GnRH) receptor antagonist.

Trials 52
article thumbnail

Survey reveals healthcare professionals believe greater collaboration is needed to improve patient outcomes in diabetes care

The Pharma Data

. “Diabetes is a complex condition, and each specialty should be prioritizing their patients’ overall health and developing treatment plans in collaboration with other specialists without worrying of overstepping,” said Javed Butler, M.D., Chairman, Department of Medicine, University of Mississippi.

Nurses 52
article thumbnail

American Heart Association, Nov. 13-17

The Pharma Data

The conference featured presentations focusing on the latest advances in cardiovascular medicine and surgery. of the University of Miami Miller School of Medicine and UM/Jackson Memorial Hospital in Miami, and colleagues found that increased greenness and better air quality are associated with decreased cardiovascular disease mortality. .

article thumbnail

Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends

XTalks

With each passing year, pharmaceutical companies around the globe strive to deliver cutting-edge medicines, therapies and vaccines that impact the lives of millions. In this in-depth article, we embark on a captivating journey to uncover the top 30 pharma and biotech companies that have been instrumental in shaping the future of medicine.

Sales 98
article thumbnail

Cardiac Biomarkers in Cardiovascular Clinical Trials: Caveats and Considerations

XTalks

While cardiac biomarkers hold much promise, there are a number of challenges in developing robust markers that can accurately reflect changes in disease biology linked to the mechanism of action of a therapeutic intervention. This is a part of the precision cardiology approach and could lead to their use as prognostic indicators.